Get more information about:
Enjoy reading!
Respiratory tract infections (RTIs) are a global health burden. They include a wide range of diseases, from common colds to severe pneumonia. A novel chitosan containing microparticle was developed as a potential drug carrier system for the treatment of RTIs.
The development of safe and effective vaccines is a major challenge. In addition to generating an adequate immune response, vaccines must also remain stable over time – both inside and outside the body. In their review article, Masimov and Wasan present various applications of chitosan and chitosan derivatives as adjuvants in the development of particulate and non-particulate vaccines.
After already high numbers in 2023, 4025 articles dealing with chitosan were published in 2024. That is 616 more than in the previous year. This development shows that chitosan, as a versatile biopolymer, is attracting more and more attention from researchers worldwide. Of the 4025 search results on PubMed, 247 were reviews. Thematically, the reviews dealt with the diverse application possibilities of chitosan.
We will attend several symposiums or fairs in 2025. We would be delighted to see you on the next event.
H. pylori infections in the stomach are difficult to combat due to the formation of antibiotic resistance, biofilms and intracellular infections. In the presented study, a hydrogel platform based on chitosan and palmitic acid will be used as an alternative to antibiotic-based therapy.
Chitosan nanofibers can be used in many different ways. In the publication presented here, electrospinning is used to produce chitosan nanofibers to improve wound healing.
chitosan, electrospinning, nanofibers, antibacterial, wound healing